Dr. Husna Baksh, M.D

NPI: 1740396092
Total Payments
$3,008
2024 Payments
$733.04
Companies
20
Transactions
131
Medicare Patients
7,736
Medicare Billing
$889,968

Payment Breakdown by Category

Food & Beverage$2,716 (90.3%)
Travel$265.53 (8.8%)
Education$26.22 (0.9%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $2,716 128 90.3%
Travel and Lodging $265.53 1 8.8%
Education $26.22 2 0.9%

Top Paying Companies

Company Total Records Latest Year
Novo Nordisk Inc $639.29 28 $0 (2020)
ModernaTX, Inc. $571.53 6 $0 (2024)
Amgen Inc. $422.28 24 $0 (2023)
Merz North America, Inc. $198.00 1 $0 (2018)
Boehringer Ingelheim Pharmaceuticals, Inc. $197.01 10 $0 (2023)
AstraZeneca Pharmaceuticals LP $183.71 12 $0 (2024)
Merck Sharp & Dohme Corporation $162.02 15 $0 (2020)
ARBOR PHARMACEUTICALS, INC. $144.10 12 $0 (2018)
Inspire Medical Systems, Inc. $122.69 1 $0 (2024)
Allergan, Inc. $95.30 6 $0 (2020)

Payment History by Year

Year Amount Transactions Top Company
2024 $733.04 9 ModernaTX, Inc. ($571.53)
2023 $72.59 4 AstraZeneca Pharmaceuticals LP ($33.07)
2021 $52.78 3 Dynavax Technologies Corporation ($21.31)
2020 $149.33 8 Novo Nordisk Inc ($36.16)
2019 $411.27 24 Amgen Inc. ($125.89)
2018 $622.50 26 Merz North America, Inc. ($198.00)
2017 $966.60 57 Novo Nordisk Inc ($350.36)

All Payment Transactions

131 individual payment records from CMS Open Payments — Page 2 of 6

Date Company Product Nature Form Amount Type
11/13/2019 Amgen Inc. Aimovig (Biological), Repatha Food and Beverage In-kind items and services $14.00 General
Category: Neuroscience
11/10/2019 Novo Nordisk Inc Tresiba (Drug) Food and Beverage In-kind items and services $22.00 General
Category: Diabetes
11/06/2019 Boehringer Ingelheim Pharmaceuticals, Inc. TRADJENTA (Drug), JARDIANCE, SYNJARDY XR Food and Beverage In-kind items and services $28.29 General
Category: DIABETES
09/24/2019 Gilead Sciences, Inc. Food and Beverage In-kind items and services $18.71 General
09/18/2019 Amgen Inc. Aimovig (Biological), Repatha Food and Beverage In-kind items and services $10.00 General
Category: Neuroscience
09/05/2019 Takeda Pharmaceuticals U.S.A., Inc. Amitiza (Drug) Food and Beverage In-kind items and services $18.18 General
Category: Lower GI
08/28/2019 Boehringer Ingelheim Pharmaceuticals, Inc. TRADJENTA (Drug), JARDIANCE, GLYXAMBI Food and Beverage In-kind items and services $17.77 General
Category: DIABETES
08/22/2019 Amgen Inc. Aimovig (Biological), Repatha Food and Beverage In-kind items and services $16.21 General
Category: Neuroscience
08/21/2019 Merck Sharp & Dohme Corporation JANUVIA (Drug), STEGLATRO Food and Beverage In-kind items and services $13.40 General
Category: ENDOCRINOLOGY
07/31/2019 Amgen Inc. Aimovig (Biological), Repatha Food and Beverage In-kind items and services $22.15 General
Category: Neuroscience
06/14/2019 Novo Nordisk Inc Tresiba (Drug) Food and Beverage In-kind items and services $21.16 General
Category: Diabetes
06/06/2019 Amgen Inc. Aimovig (Biological) Food and Beverage In-kind items and services $13.29 General
Category: Neuroscience
05/23/2019 Lilly USA, LLC EMGALITY (Drug) Food and Beverage In-kind items and services $11.62 General
Category: Neuroscience
05/09/2019 Allergan Inc. LINZESS (Drug) Food and Beverage In-kind items and services $11.03 General
Category: GASTROENTEROLOGY
04/24/2019 Novo Nordisk Inc Ozempic (Drug) Food and Beverage In-kind items and services $17.78 General
Category: Diabetes
04/11/2019 Amgen Inc. Aimovig (Biological), Repatha Food and Beverage In-kind items and services $17.42 General
Category: Neuroscience
04/10/2019 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug), GLYXAMBI Food and Beverage In-kind items and services $20.86 General
Category: DIABETES
03/28/2019 Novo Nordisk Inc Tresiba (Drug) Food and Beverage In-kind items and services $19.65 General
Category: Diabetes
03/20/2019 Amgen Inc. Aimovig (Biological), Repatha Food and Beverage In-kind items and services $12.77 General
Category: Neuroscience
02/13/2019 Novo Nordisk Inc Ozempic (Drug) Food and Beverage In-kind items and services $17.52 General
Category: Diabetes
02/11/2019 Phadia US Inc. ImmunoCAP (Device) Food and Beverage Cash or cash equivalent $13.56 General
Category: Allergy/Immunology
01/17/2019 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $18.33 General
Category: Cardiovascular and Metabolism
01/16/2019 Amgen Inc. Aimovig (Biological), Prolia, Repatha Food and Beverage In-kind items and services $20.05 General
Category: Neuroscience
12/04/2018 Amgen Inc. Prolia (Biological), Repatha Food and Beverage In-kind items and services $18.23 General
Category: Endocrinology
11/28/2018 AstraZeneca Pharmaceuticals LP XIGDUO (Drug) Food and Beverage In-kind items and services $14.61 General
Category: Cardiovascular and Metabolism

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 34 2,261 5,909 $993,685 $262,597
2022 32 2,625 4,430 $971,593 $272,055
2021 20 1,494 2,069 $554,799 $188,473
2020 25 1,356 2,708 $332,601 $166,844
Total Patients
7,736
Total Services
15,116
Medicare Billing
$889,968
Procedure Codes
111

All Medicare Procedures & Services

111 procedure records from CMS Medicare Utilization — Page 2 of 5

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99443 Telephone medical discussion with physician, 21-30 minutes Office 2023 22 24 $7,296 $1,607 22.0%
93015 Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician Office 2023 22 22 $5,720 $1,339 23.4%
99458 Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes Office 2023 17 33 $3,960 $1,126 28.4%
G0008 Administration of influenza virus vaccine Office 2023 31 31 $2,263 $1,074 47.4%
94681 Test to measure exhaled air and carbon dioxide for evaluation of lung function Office 2023 22 22 $3,322 $930.93 28.0%
G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or Office 2023 28 35 $3,290 $742.53 22.6%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 11 11 $3,366 $503.80 15.0%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 35 35 $2,345 $455.71 19.4%
99453 Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment Office 2023 26 26 $1,534 $360.38 23.5%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 240 573 $232,065 $62,197 26.8%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 194 194 $69,156 $28,640 41.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 189 355 $107,920 $25,378 23.5%
99457 Management using the results of remote vital sign monitoring per calendar month, first 20 minutes Office 2022 91 507 $74,529 $22,693 30.4%
99497 Advance care planning, first 30 minutes Office 2022 225 225 $53,775 $18,811 35.0%
95923 Testing of autonomic (sympathetic) nervous system function Office 2022 140 140 $85,540 $16,399 19.2%
99454 Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days Office 2022 74 362 $69,866 $13,182 18.9%
95921 Testing of autonomic nervous system function and heart rate response to deep breathing Office 2022 140 140 $36,120 $11,524 31.9%
93922 Ultrasound study of arm and leg arteries Office 2022 105 137 $35,081 $9,922 28.3%
99458 Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes Office 2022 63 253 $30,360 $9,204 30.3%
93925 Ultrasound of leg arteries or artery grafts Office 2022 33 35 $21,916 $7,278 33.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 108 135 $27,810 $6,458 23.2%
93923 Complete ultrasound study of arm and leg arteries Office 2022 38 38 $15,770 $4,688 29.7%
G0444 Annual depression screening, 15 minutes Office 2022 196 196 $9,996 $4,244 42.5%
99443 Telephone medical discussion with physician, 21-30 minutes Office 2022 36 50 $15,200 $4,186 27.5%
90662 Influenza vaccine split virus, preservative free Office 2022 51 52 $8,476 $3,482 41.1%

About Dr. Husna Baksh, M.D

Dr. Husna Baksh, M.D is a Family Medicine healthcare provider based in Silver Spring, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740396092.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Husna Baksh, M.D has received a total of $3,008 in payments from pharmaceutical and medical device companies, with $733.04 received in 2024. These payments were reported across 131 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($2,716).

As a Medicare-enrolled provider, Baksh has provided services to 7,736 Medicare beneficiaries, totaling 15,116 services with total Medicare billing of $889,968. Data is available for 4 years (2020–2023), covering 111 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Other Specialties Internal Medicine
  • Location Silver Spring, MD
  • Active Since 08/21/2006
  • Last Updated 04/26/2017
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1740396092

Products in Payments

  • Victoza (Drug) $247.76
  • Prolia (Biological) $226.52
  • Tresiba (Drug) $212.42
  • XEOMIN (Biological) $198.00
  • Ozempic (Drug) $154.19
  • FARXIGA (Drug) $130.00
  • Aimovig (Biological) $125.89
  • INSPIRE (Device) $122.69
  • JANUVIA (Drug) $118.35
  • TRADJENTA (Drug) $103.45
  • JARDIANCE (Drug) $93.56
  • Edarbi (Drug) $54.63
  • EVENITY (Biological) $51.18
  • ImmunoCAP (Device) $47.95
  • LINZESS (Drug) $40.72
  • HUMALOG (Drug) $37.74
  • VIBERZI (Drug) $34.35
  • Otovel (Drug) $31.78
  • ASMANEX (Drug) $27.67
  • Saxenda (Drug) $24.92

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Silver Spring